TwinBeech Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-51,366
Closed -$985K 688
2026
Q1
$985K Buy
+51,366
New +$1.12M 0.1% 250
2024
Q3
Sell
-40,801
Closed -$1.64M 896
2024
Q2
$1.64M Buy
+40,801
New +$1.7M 0.03% 352
2023
Q3
Sell
-48,469
Closed -$1.19M 896
2023
Q2
$1.19M Buy
+48,469
New +$1.56M 0.02% 437
2022
Q2
Sell
-7,350
Closed -$855K 735
2022
Q1
$855K Buy
+7,350
New +$858K 0.04% 337

Other funds holding TNDM

TwinBeech Capital's TNDM Position: Q2 2026 in Review

TwinBeech Capital sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 51,366 shares — an estimated $985K sold.

TwinBeech Capital first reported a position in TNDM in Q1 2022 and held it in 4 quarters. The position peaked at $1.64M in Q2 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • TwinBeech Capital reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • TwinBeech Capital sold 51,366 Tandem Diabetes Care shares in Q2 2026, an estimated $985K.
  • TwinBeech Capital first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 4 quarters.
  • TwinBeech Capital's Tandem Diabetes Care position peaked at $1.64M in Q2 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.